ATE160448T1 - Nachweis von thrombopenies - Google Patents

Nachweis von thrombopenies

Info

Publication number
ATE160448T1
ATE160448T1 AT91915653T AT91915653T ATE160448T1 AT E160448 T1 ATE160448 T1 AT E160448T1 AT 91915653 T AT91915653 T AT 91915653T AT 91915653 T AT91915653 T AT 91915653T AT E160448 T1 ATE160448 T1 AT E160448T1
Authority
AT
Austria
Prior art keywords
inducer drug
thrombocytopeniae
inducer
drug
antigenic substance
Prior art date
Application number
AT91915653T
Other languages
English (en)
Inventor
Jean Amiral
Original Assignee
Stago Diagnostica
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Stago Diagnostica filed Critical Stago Diagnostica
Application granted granted Critical
Publication of ATE160448T1 publication Critical patent/ATE160448T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/86—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5091—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing the pathological state of an organism
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56966—Animal cells
    • G01N33/56972—White blood cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2400/00—Assays, e.g. immunoassays or enzyme assays, involving carbohydrates
    • G01N2400/10—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • G01N2400/38—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence, e.g. gluco- or galactomannans, Konjac gum, Locust bean gum or Guar gum
    • G01N2400/40—Glycosaminoglycans, i.e. GAG or mucopolysaccharides, e.g. chondroitin sulfate, dermatan sulfate, hyaluronic acid, heparin, heparan sulfate, and related sulfated polysaccharides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Rehabilitation Therapy (AREA)
  • Rheumatology (AREA)
  • Zoology (AREA)
  • Virology (AREA)
  • Physiology (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Iron Core Of Rotating Electric Machines (AREA)
  • Electrophonic Musical Instruments (AREA)
  • Magnetic Record Carriers (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT91915653T 1990-08-09 1991-08-09 Nachweis von thrombopenies ATE160448T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9010190A FR2665769B1 (fr) 1990-08-09 1990-08-09 Determination des thrombopenies notamment induites par l'heparine au moyen du facteur plaquettaire 4.

Publications (1)

Publication Number Publication Date
ATE160448T1 true ATE160448T1 (de) 1997-12-15

Family

ID=9399577

Family Applications (1)

Application Number Title Priority Date Filing Date
AT91915653T ATE160448T1 (de) 1990-08-09 1991-08-09 Nachweis von thrombopenies

Country Status (7)

Country Link
EP (1) EP0495971B1 (de)
JP (1) JP2821951B2 (de)
AT (1) ATE160448T1 (de)
DE (1) DE69128238T2 (de)
ES (1) ES2110998T3 (de)
FR (1) FR2665769B1 (de)
WO (1) WO1992002823A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5585243A (en) * 1993-09-15 1996-12-17 The Blood Center Of Southeastern Wisconsin, Inc. Method of detecting cytopenia that is mediated by drug-dependent antibody binding to blood cells
US5972717A (en) * 1995-05-10 1999-10-26 The Blood Center Research Foundation, Inc. Method and kit for detecting heparin induced thrombocytopenia
FR2738916B1 (fr) * 1995-09-20 1997-11-14 Stago Diagnostica Procede d'identification precoce d'une maladie auto-immune, utilisation dans le domaine du diagnostic et necessaire de dosage pour mettre en oeuvre ce procede
WO1998022821A1 (en) * 1996-11-21 1998-05-28 Merck & Co., Inc. DETECTION OF ANTAGONIST-DEPENDENT GPIIb/IIIa RECEPTOR ANTIBODIES
WO2006042089A2 (en) 2004-10-04 2006-04-20 Akers Biosciences, Inc. Methods and kits for detecting heparin/platelet factor 4 antibodies
WO2010024271A1 (ja) * 2008-08-27 2010-03-04 三菱化学メディエンス株式会社 修飾抗ヘパリン／pf4複合体抗体及びhit抗体標準品
ES2862434T3 (es) * 2017-08-02 2021-10-07 Siemens Healthcare Diagnostics Products Gmbh Prueba de unión para el diagnóstico de trombocitopenia inducida por heparina

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4717654A (en) * 1984-06-19 1988-01-05 Akzo N.V. Process for solid phase platelet antibody assay

Also Published As

Publication number Publication date
JP2821951B2 (ja) 1998-11-05
JPH05502103A (ja) 1993-04-15
WO1992002823A1 (fr) 1992-02-20
ES2110998T3 (es) 1998-03-01
DE69128238T2 (de) 1998-06-25
EP0495971B1 (de) 1997-11-19
DE69128238D1 (de) 1998-01-02
EP0495971A1 (de) 1992-07-29
FR2665769B1 (fr) 1994-04-29
FR2665769A1 (fr) 1992-02-14

Similar Documents

Publication Publication Date Title
Stathakis et al. Interactions among heparin, cold-insoluble globulin, and fibrinogen in formation of the heparin-precipitable fraction of plasma
Fernandez et al. Chemotactic response to human C3a and C5a anaphylatoxins: I. Evaluation of C3a and C5a leukotaxis in vitro and under simulated in vivo conditions
ATE223044T1 (de) Nachweis von retikulozyten mit coriphosphin o
PT90574A (pt) Processo de preparacao de polipeptidos e de determinacao da presenca de anticorpos de proteina latente anti-virus do papiloma
FI871288A0 (fi) Menetelmä aprotiniinin valmistamiseksi yhdistelmä-DNA-tekniikalla ja menetelmään soveltuva DNA, ilmentämisplasmidi ja isäntäsolu
DE59208032D1 (de) Funktioneller Test und Reagenz zur Bestimmung von Fibrinogen
DE59109048D1 (de) Inhibitoren zur antikoagulierenden Vorbehandung von Blutproben
ATE161967T1 (de) Verfahren für das screening von plasma-proben für einen effektiven antikörpernachweis gegen respiratorische viren
ATE15274T1 (de) Verfahren und ausruestung zum testen von antikoerpern gegen loesliche antigene.
NO872036D0 (no) Analyseelement for bestemmelse av koagulasjonsparametere.
ATE160448T1 (de) Nachweis von thrombopenies
ES2079621T3 (es) Procedimiento de identificacion o de titulacion de proteinas y aplicaciones.
Binette et al. The proteins of synovial fluid: A study of the α1/α2 globulin ratio
ATE191792T1 (de) Verfahren zur detektion von hepatitis c
Melliger Detection of fibrinogen degradation products by use of antibody coated latex particles
ATE107418T1 (de) Nachweis von analyt in partikel enthaltenden proben.
SE8004542L (sv) Diagnostiskt test
DE3889279D1 (de) Diagnostisches Mittel und Verfahren zur Bestimmung von Apolipoprotein B.
ATE191568T1 (de) Spezifische bindungssubstanzen für antikörper und deren verwendung für immunoassays oder vakzine
ATE143142T1 (de) Immunoassay zum nachweis von antikörpern gegen hiv
DE2961056D1 (en) Stabilized platelet factor 4 immunoassay standards and radio-immunoassay method
Fiedel et al. Further studies on the modulation of blood coagulation by human serum amyloid P component and its acute phase homologue C-reactive protein
DK0445626T3 (da) Funktionel test til bestemmelse af protein S-aktivitet.
DE60033190D1 (de) Verfahren zum nachweis von hepatitis c antigenen
Pattison et al. Elution patterns of rubella IgM, IgA, and IgG antibodies from a dextran and an agarose gel.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties